Author:
Sigsgaard T,Herrstedt J,Andersen L J,Havsteen H,Langer S W,Kjærbøl A-G,Lund H,Kjær M,Dombernowsky P
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Aapro, M. S. (1991). Controling emesis related to cancer therapy. Eur J Cancer 27: 356–361.
2. Adams, V. R. & Valley, A. W. (1995). Granisetron: the second serotonin-receptor antagonist. Ann Pharmacother 29: 1240–1251.
3. Andrews, P. L. R. & Davis, C. J. (1993). The mechanism of emesis induced by anticancer therapies. In Emesis in Anticancer Therapy, 1st Edn, Andrews PLA and Sanger GJ (eds), pp. 113–161. Chapman & Hall: London
4. Blijham, H. G. (1992). Does granisetron remain effective over multiple cycles? Eur J Cancer 28A: S17–S21.
5. Bonneterre, J., Chevallier, B., Metz, R., Fargeot, P., Pujade-Laurine, E., Spielmann, M., Tubiana-Hulin, M., Paes, D. & Bons, J. (1990). A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy. J Clin Oncol 8: 1063–1069.
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献